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OBJECTIVES: Population aging raises concerns regarding the increases in the rates of morbidity and mortality that
result from influenza and its complications. Although vaccination is the most important tool for preventing
influenza, vaccination program among high-risk groups has not reached its predetermined aims in several settings.
This study aimed to evaluate the impacts of clinical and demographic factors on vaccine compliance among the
elderly in a setting that includes a well-established annual national influenza vaccination campaign.
METHODS: This cross-sectional study included 134 elderly patients who were regularly followed in an academic
medical institution and who were evaluated for their influenza vaccination uptake within the last five years; in
addition, the demographic and clinical characteristics and the reasons for compliance or noncompliance with the
vaccination program were investigated.
RESULTS: In total, 67.1% of the participants received the seasonal influenza vaccine in 2009. Within this vaccination-
compliant group, the most common reason for vaccine uptake was the annual nationwide campaign (52.2%; 95%
CI: 41.4–62.9%); compared to the noncompliant group, a higher percentage of compliant patients had been advised
by their physician to take the vaccine (58.9% vs. 34.1%; p,0.01).
CONCLUSION: The education of patients and health care professionals along with the implementation of
immunization campaigns should be evaluated and considered by health authorities as essential for increasing the
success rate of influenza vaccination compliance among the elderly.
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INTRODUCTION
Population aging is a worldwide phenomenon, as the
proportion of people who are age 60 years and older is
increasing faster than any other age group, with an expected
increase of 694 million (or 223%) from 1970 to 2025.
1
Although the countries with the highest proportions of
elderly people are in Europe, approximately 70% of the
current global older population lives in developing coun-
tries; these countries must deal with the potential increases
in economic, health and social demands that are related to
aging.
In addition to neoplastic and degenerative diseases, some
infectious complications, including those that are caused by
influenza, occur more frequently among elderly indivi-
duals,
2 who suffer the highest rates of serious illness and
death that are associated with the disease.
3,4,5
Therefore, influenza is a growing issue for public health
and geriatric medicine concerns; consequently, seasonal
vaccination is recommended for elderly individuals in
several countries.
6 Among the elderly, vaccination con-
tinues to be the most important tool for preventing
influenza-related morbidity and mortality
7,8 and is asso-
ciated with reduced hospitalizations due to pneumonia or
influenza and for any cause in community-dwelling older
persons.
3 In Brazil, a national influenza immunization
campaign that targets individuals 60 years of age and older
has been conducted since 1999;
9 since its inception, reduced
hospitalizations associated with respiratory diseases have
been verified in this age group.
10,11
Among high-risk groups, complying with this vaccination
is essential to the success of preventive programs that target
influenza; however, vaccination coverage among these
groups has not reached the established aims in several
developed or developing countries.
12-16 The World Health
Organization (WHO) has established goals for increasing
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2031the coverage of influenza vaccination among high-risk
populations and has encouraged countries to implement
initiatives to raise awareness of influenza and influenza
vaccination among the public, although they have not
indicated which initiatives should be adopted.
17
Several studies that were conducted in Europe and North
America identified risk factors for noncompliance with
influenza vaccination among the elderly, including low
income,
18,19 African-American ethnicity,
12,20 a good self-
perception of health,
21,22 younger age,
12,14,19,21 cognitive
impairments,
19 living alone,
19 and fear of adverse events
following vaccination.
18,22 In Brazil, two recent population-
based surveys reported that age, smoking, and a lack of an
appointment with a physician in the previous year were all
independently associated with vaccination noncompliance.
In addition, other reasons that were reported were a fear of
adverse events following vaccination and a lack of concern
regarding the influenza disease itself. The most widely cited
source of information regarding the vaccine was the
television (66.4%), and the second most frequent source
was friends (25.3%), whereas nurses and doctors were cited
by only 10.4% and 5.3% of the interviewees, respectively. It
was more alarming that in one of the studies, only 10% of
the participants mentioned a recommendation by a physi-
cian as their motivation for vaccine compliance.
23,24
The influence of counseling by physicians and other
health care professionals regarding influenza vaccination
compliance requires further investigation. It is also con-
ceivable that health care professionals who are involved
with primary health care or with the treatment of
respiratory diseases, including family physicians, gerontol-
ogists, and pulmonologists, might be more prone to
recommend the influenza vaccination to their patients,
which is a hypothesis that needs to be explored further.
This study was designed to evaluate the impacts of
clinical and demographic factors on vaccine compliance
among the elderly in a setting that includes a well-
established annual national influenza vaccination campaign.
METHODS
This was a cross-sectional study that was conducted in the
city of Sa ˜o Paulo, Brazil, between two and five months after
the close of the 2009 influenza seasonal vaccination national
campaign. The study included patients who were 60 years
of age or older and were followed regularly in four different
outpatient services (i.e., the Geriatrics, Urology, Pulmo-
nology, and Rheumatology clinics) in a tertiary academic
medical institution. The study was approved by the Ethics
Committee of the University of Sa ˜o Paulo Medical School.
Patients who attended any of the four aforementioned
clinics were invited to participate in the study and were
interviewed at the hospital after providing informed
consent. The interviews were conducted twice weekly on
various weekdays during the study period, and all patients
who were attending the clinics for their medical appoint-
ments were invited to participate. Information was obtained
regarding the influenza vaccination status for the previous
five years, the demographic and clinical characteristics, and
the reasons for compliance or noncompliance with the
vaccination program. The reasons for vaccination compli-
ance or noncompliance were obtained via an open question.
The demographic and clinical characteristics of the two
groups of patients (i.e., those who had been compliant and
those who had been noncompliant with the seasonal
influenza vaccination in 2009) were compared using the
Pearson’s Chi-square test or the two-sided Fisher’s exact test
for analyzing the categorical variables or using the two-
sample Student’s t-test, assuming equal variances for
analyzing the continuous variables.
The 95% confidence intervals for the percentages of the
reasons for vaccination compliance or noncompliance were
calculated using the exact binomial method.
The percentages of physicians who had recommended the
seasonal influenza vaccination in each clinic were compared
using the two-sided Fisher’s exact test, and clinics were
compared individually using the Pearson’s Chi-square test
when the clinics were pooled. The following comparisons
were performed when the clinics were pooled: the Geriatric
clinic versus the other clinics, the Pulmonology clinic versus
the other clinics, and the Geriatric and Pulmonology clinics
versus the Urology and Rheumatology clinics. The
Bonferroni correction was used to adjust for multiple
comparisons.
Logistic regression was performed to identify the vari-
ables that were associated with compliance with the
seasonal influenza vaccination. The following variables
were included in the initial model: age, ethnicity, years of
education, income, hospital admissions during the previous
year, whether they lived alone and/or attended the clinic
alone, whether they had a caregiver, if they provided a good
self-evaluation of health, the presence of any chronic health
condition, the use of medication for a chronic health
condition, memory loss, and the recommendation for
vaccination by the physician. The backward stepwise
regression procedure, with a p-value of 0.05 for backward
selection, was used to obtain the final model for the logistic
regression analysis.
Each statistical test useda significancelevelof 0.05 and was
performed using STATA version 10.1 software (StataCorp,
College Station, TX, USA).
RESULTS
A total of 134 patients accepted to participate in the study.
These patients had a mean age of 76.2 years (SD ¡ 8.1) and
were primarily included in the Geriatrics clinic (65.7%),
followed by the Pulmonology (14.2%), Rheumatology (12%),
and Urology (8.1%) clinics. Overall, 67.1% (95% CI: 58.5–
75%) of the participants had taken the seasonal influenza
vaccine in 2009. The characteristics of the patients were
stratified by compliance or noncompliance with their
seasonal influenza vaccine in 2009. The data are presented
in Table 1.
Within the vaccination-compliant group, a higher percen-
tage of patients were receiving medication for a chronic
condition than in the noncompliant group (98.9% vs. 90.9%,
respectively; p,0.05), and a higher percentage had taken
their influenza vaccine in 2008 (93.3% vs. 18.2%, respec-
tively; p,0.05) or at least once in the previous four years
(95.2% vs. 26.8%, respectively; p,0.05). In the compliant
group, the most frequently cited motivation to take the
vaccine was the annual nationwide campaign that was held
by the Brazilian Ministry of Health (52.2%; 95% CI: 41.4–
62.9%), which was followed by a belief in the protective
effect of the vaccine (37.7%; 95% CI: 27.8–48.6%) and
recommendation by a physician (35.5%; 95% CI: 25.7–
46.3%). Other less frequently mentioned reasons included
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2032the lack of side effects, the prevention of pneumonia,
vaccination as part of their routine medical care, and
frequent episodes of influenza disease (Table 2). A higher
percentage of patients in the vaccination-compliant group
had been advised by their personal physician to take the
vaccine (58.9% vs. 34.1%; p,0.05).
Within the vaccination-noncompliant group, the reason
that was most frequently cited as their reason to not take the
vaccine was the belief that it could induce influenza (36.4%;
95% CI: 22.4–52.2%), which was followed by the belief that
the vaccine causes other side effects (16%; 95% CI: 6.6–30%)
and the idea that they rarely contracted influenza (16%; 95%
CI: 6.6–30%). Other less frequently mentioned reasons
included pain due to the vaccine administration and
transportation difficulties. Previous vaccine side effects
were not reported as reasons to avoid taking the vaccine
(Table 2).
The medical recommendation for the influenza vaccine
was not statistically different among the four outpatient
clinics when evaluated separately (p=0.25) or when
analyzed in the following combinations: Geriatrics versus
the other clinics (p=0.6), Pulmonology versus other clinics
(p=1.0), and Geriatrics and Pulmonology versus the
Rheumatology and Urology clinics (p=0.13).
The logistic regression model revealed that a recommen-
dation from a physician to take the vaccine was the only
variable that was significantly associated with vaccine
compliance. Patients in the vaccination-compliant group
had a likelihood of receiving a recommendation that was
2.7-fold higher than the vaccination-noncompliant group
(OR=2.7; 95% CI=1.29–5.6; p,0.05).
DISCUSSION
We believe that preventing influenza among the elderly
through vaccination is certainly one of the primary public
Table 1 - Characteristics of the interviewed patients according to their seasonal influenza vaccine uptake in 2009.
Vaccine Uptake
Yes (n=90) No (n=44)
n (%) p-value*
Age (mean) 76.3 75.9 0.8
{
Male 25 (27.8) 16 (36.4) 0.31
Ethnicity 0.22
Caucasian 67 (74.4) 29 (65.9)
Black 9 (10) 4 (9.1)
Mulatto 9 (10) 10 (22.7)
Asian 5 (5.6) 1 (2.3)
Years of education 0.16
,4 27 (30) 14 (31.8)
4t o8 48 (53.3) 17 (38.6)
.8 13 (29.5) 15 (16.7)
Income
{ 0.15
,2X minimum wage 31 (34.4) 21 (47.7)
2 to 4X minimum wage 47 (52.2) 20 (45.5)
.4X minimum wage 12 (13.3) 2 (4.6)
Had a housemate 67 (74.4) 38 (86.4) 0.12
Attended health services alone 40 (44.4) 22 (50) 0.54
Had a caregiver 22 (24.4) 12 (27.2) 0.72
Had regular medical follow-up 89 (98.9) 44 (100) 1**
Personal physician recommended the vaccine 53 (58.9) 15 (34.1) 0.007
Had any chronic disease 88 (97.7) 43 (97.7) 1**
Long-term use of medication 89 (98.9) 40 (90.9) 0.04**
Referred memory loss 53 (58.9) 20 (45.5) 0.14
Good self-evaluation of health status 52 (57.8) 25 (56.8) 0.91
Hospital admission during the previous year 22 (24.4) 6 (13.6) 0.15
Took the seasonal influenza vaccine in 2008 84 (93.3) 8 (18.2) ,0.001
Took the seasonal influenza vaccine at least once in the previous 4
years
79 (95.2) 11 (26.8) ,0.001
*Chi-square test (unless otherwise indicated).
**Fisher’s exact test.
{Two-sample t-test.
{The Brazilian minimum wage is approximately US$ 302.00 per month.
Table 2 - Referenced reasons for influenza vaccination
compliance or noncompliance in 2009.
For compliance % (95% CI)
National influenza vaccination
campaign
52.2 (41.4–62.9)
Believed the influenza vaccine
is protective
37.7 (27.8–48.6)
Physician recommended it 35.5 (25.7–46.3)
Another health care
professional recommended it
1.1 (0–6)
For noncompliance % (95% CI)
Believed the influenza vaccine
causes influenza disease
36.4 (22.4–52.2)
Fear of adverse events 15.9 (6.6–30)
Believed they would never
contract influenza
15.9 (6.6–30)
Lack of transportation 9 (0–17.9)
Pain 4.6 (0–15.8)
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2033health goals that governments worldwide should pursue to
promote their health and disease prevention policies and
achieve an improved quality of life in old age, according to
the ‘‘active aging’’ framework established by the WHO.
A prerequisite for the widespread vaccination of high-risk
groups is more equitable access to the vaccine, and this has
been partially addressed by the Global Action Plan (GAP),
outlined by the WHO, in which they projected a sharp
increase for 2010 in the annual production capacity of
trivalent seasonal influenza vaccine to more than 800
million doses and noted that production capacity is
currently available, or is being established, in 25 countries,
including developing countries.
25 Once the influenza
vaccine is available in sufficient quantities, governments
then face the challenge of achieving high coverage among
high-risk groups.
This study gathered additional evidence to facilitate the
planning and improvement of strategies and initiatives that
seek to increase the uptake of influenza vaccinations among
the elderly. This population is not homogeneous, and this is
reflected by the various risk factors that were identified for
poor vaccination uptake; the initiatives should reflect this
heterogeneity. In this regard, this study provides valuable
information regarding a specific subset of older individuals
who are followed regularly in a tertiary teaching hospital
and who likely have a number of comorbidities.
A recommendation by a physician was found to be a key
factor for compliance; this is consistent with other studies.
However, doctors are also not a homogeneous population,
even in an academic medical institution, and a high
proportion of doctors did not advise their patients regarding
the influenza vaccination. The association of counseling that
is performed by physicians and other health care profes-
sionals with influenza vaccination should be explored
further in future studies and should be considered in
initiatives that seek to improve vaccination uptake, includ-
ing vaccination campaigns.
Another aspect that should be considered an essential
element of any influenza vaccination program is the imple-
mentation of campaigns to instruct the population regarding
the risks and benefits of the vaccine. The various reasons for
vaccine uptake included the beliefin vaccine efficacy, whereas
the reasons for a lack of compliance included misinformation
regarding influenza and the influenza vaccine.
Finally, the most frequent reason that was cited by the
patients as their motivation to take the vaccine was the
Figure 1 - Strategies that were adopted by the Brazilian government to promote and maintain influenza vaccine coverage among older
persons. Adapted from the National Influenza Immunization Campaign Targeting Older Persons Technical Report, Brazil, Ministry of
Health, 2007.
9
Figure 2 - Percentage of Brazilian cities with at least 70% influenza vaccine coverage from 1999 through 2006. Adapted from the
National Influenza Immunization Campaign Targeting Older Persons Technical Report, Brazil, Ministry of Health, 2007.
9
Compliance with the influenza vaccine among the elderly
Avelino-Silva VI et al.
CLINICS 2011;66(12):2031-2035
2034annual nationwide influenza vaccination campaign.
National influenza immunization campaigns that target
older persons have been conducted in Brazil since 1999,
which was considered The International Year of Older
Persons. Several strategies have been used by the Brazilian
government to promote and maintain influenza vaccine
coverage among older persons (Figure 1) including the
participation of medical societies, social organizations, radio
and TV stations, and the presence of additional health care
professionals, thereby minimizing long waiting lines and
system malfunctions.
9 In the initial years of campaigning,
population compliance with the vaccine was moderate; it
was generally believed that vaccines should only be
administered to children, and the benefits of influenza
vaccination in the elderly were not yet fully understood. In
addition, myths, such as the occurrence of flu-like symp-
toms following vaccination, helped propagate distrust
towards the vaccine. However, the annual campaigns were
continued, and after 2003, more than 90% of Brazilian cities
reached the 70% vaccine coverage goal (Figure 2).
9 In
addition to this experience in Brazil, other authors have
analyzed similar strategies for mass influenza vaccination in
various settings
26,27 and found that these strategies can be
cost-effective.
The primary limitations of this study are the sample size
and source population, which came from a tertiary
academic medical institution. Our sample included a large
proportion of patients with more severe and complex
diseases, and most of the patients were receiving medication
for chronic conditions. For this particular population, the
reasons for vaccination compliance may not reflect those of
the elderly in the general; therefore, our findings cannot be
generalized, and any inferences from our results should be
carefully considered.
The success of influenza vaccination program among the
elderly will likely depend on multiple demographic and
clinical factors that can vary from region to region and
should be evaluated by local health authorities, along with
actions, such as vaccination campaigns and educating both
the target population and health care professionals.
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